Asana BioSciences

Asana BioSciences is owned by Amneal Pharmaceuticals.

Amneal Pharmaceuticals is one of the...

• Russell 3000.

Amneal Pharmaceuticals is a company listed under the stock ticker AMRX (US).

View the org chart displaying its 4 main executives

Most searched biographies at Asana BioSciences

• Sandeep Gupta, President and Chief Executive Officer
• Shashank Mahashabde, Vice President, Chemistry, Manufacturing and ...
• Anna Binder, Head of People Operations

Create your alert
to follow the executive moves at Asana BioSciences.

Amneal Pharmaceuticals has 1,860 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma
• Lucia Aleotti - Director at Menarini Group

Learn more about the Pharmaceuticals industry >

Press releases by Asana BioSciences

• Asana BioSciences’ JAK/SYK Inhibitor Performs Well in Phase 2b Study of Hand Eczema - Practical DermatologydownarrowsearchsearchsearchdownarrowlinkPD-BMC-Group
• Asana BioSciences’ Gusacitinib Granted FDA Fast-Track Designation for Moderate-to-Severe Chronic Hand Eczema | Business Wire
• Asana News

Social media about Asana BioSciences

• Asana BioSciences on Wikipedia, Google News & Yahoo Finance
• Asana BioSciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Sandeep Gupta

Call Asana BioSciences at +1 908...

View the org chart

Register to receive your alert

Report an error